Skip to content
Home/Companies/Pharma/Verretubex
Verretubex

Verretubex

Pharma·France·Active·12yr hold
Entry
2014
Hold
12yr
Status
Active

Who owns Verretubex?

Verretubex is a French Pharma company, currently owned by Capitem Partenaires since 2014.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Capitem Partenaires
Investor
Capitem Partenaires
FPCI Capitem 1 · 2013 · Buyout

Key facts

HQFrance
SectorPharma
StatusActive
Websitewww.verretubex.com

More from FPCI Capitem 1

Other portfolio companies in the same fund.

Groupe Clinique Developpement
Exited 2020
HealthcareFrance· 2017
to LNA Sante
Proxival
Exited 2023
IT ServicesFrance· 2017
to TrustTeam
Proson
Proson
Active
Business ServicesFrance· 2016
Securinfor
Exited 2019
IT ServicesFrance· 2016
to Paluel-Marmont Capital
Novencia
Exited 2019
IT ServicesFrance· 2015
to Arnaud Zilliox (founder-CEO)
Legoupil Industrie
Legoupil Industrie
Exited 2018
ConstructionFrance· 2014
to Groupe Treuil

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Verretubex?

Verretubex is currently owned by Capitem Partenaires, through FPCI Capitem 1, since 2014.

When did Capitem Partenaires acquire Verretubex?

Capitem Partenaires acquired Verretubex in 2014.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue